Arvest Bank Trust Division’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $280K | Sell |
2,011
-394
| -16% | -$55.2K | 0.02% | 192 |
|
|
2025
Q4 | $295K | Sell |
2,405
-212
| -8% | -$25.8K | 0.02% | 177 |
|
|
2025
Q3 | $290K | Sell |
2,617
-159
| -6% | -$18.1K | 0.02% | 180 |
|
|
2025
Q2 | $308K | Sell |
2,776
-89,297
| -97% | -$9.5M | 0.02% | 161 |
|
|
2025
Q1 | $10.3M | Sell |
92,073
-15,543
| -14% | -$1.6M | 0.65% | 51 |
|
|
2024
Q4 | $9.94M | Sell |
107,616
-7,610
| -7% | -$685K | 0.6% | 51 |
|
|
2024
Q3 | $9.66M | Buy |
+115,226
| New | +$8.79M | 0.56% | 55 |
|
|
2021
Q3 | $11.7M | Sell |
167,130
-4,353
| -3% | -$306K | 0.65% | 49 |
|
|
2021
Q2 | $11.8M | Sell |
171,483
-2,300
| -1% | -$154K | 0.65% | 49 |
|
|
2021
Q1 | $11.2M | Sell |
173,783
-2,471
| -1% | -$159K | 0.65% | 46 |
|
|
2020
Q4 | $10.3M | Sell |
176,254
-2,643
| -1% | -$159K | 0.64% | 42 |
|
|
2020
Q3 | $11.3M | Sell |
178,897
-5,591
| -3% | -$388K | 0.81% | 39 |
|
|
2020
Q2 | $14.2M | Buy |
184,488
+585
| +0.3% | +$44.8K | 1.05% | 32 |
|
|
2020
Q1 | $13.7M | Sell |
183,903
-21,393
| -10% | -$1.48M | 1.27% | 28 |
|
|
2019
Q4 | $13.3M | Sell |
205,296
-5,543
| -3% | -$361K | 0.86% | 42 |
|
|
2019
Q3 | $13.4M | Sell |
210,839
-5,823
| -3% | -$381K | 0.92% | 39 |
|
|
2019
Q2 | $14.6M | Sell |
216,662
-5,576
| -3% | -$367K | 1% | 36 |
|
|
2019
Q1 | $14.4M | Sell |
222,238
-1,608
| -0.7% | -$107K | 1% | 36 |
|
|
2018
Q4 | $14M | Sell |
223,846
-263
| -0.1% | -$18.4K | 1.12% | 28 |
|
|
2018
Q3 | $17.3M | Sell |
224,109
-3,567
| -2% | -$269K | 1.17% | 28 |
|
|
2018
Q2 | $16.1M | Sell |
227,676
-2,022
| -0.9% | -$143K | 1.15% | 27 |
|
|
2018
Q1 | $17.3M | Sell |
229,698
-2,388
| -1% | -$190K | 1.23% | 25 |
|
|
2017
Q4 | $16.6M | Sell |
232,086
-7,576
| -3% | -$575K | 1.16% | 31 |
|
|
2017
Q3 | $19.4M | Buy |
239,662
+1,120
| +0.5% | +$85.6K | 1.38% | 20 |
|
|
2017
Q2 | $16.9M | Buy |
238,542
+2,665
| +1% | +$177K | 1.28% | 25 |
|
|
2017
Q1 | $16M | Sell |
235,877
-6,117
| -3% | -$430K | 1.26% | 24 |
|
|
2016
Q4 | $17.3M | Sell |
241,994
-2,062
| -0.8% | -$153K | 1.39% | 20 |
|
|
2016
Q3 | $19.3M | Sell |
244,056
-558
| -0.2% | -$45.3K | 1.6% | 16 |
|
|
2016
Q2 | $20.4M | Buy |
244,614
+429
| +0.2% | +$38.1K | 1.75% | 15 |
|
|
2016
Q1 | $22.4M | Buy |
244,185
+5,824
| +2% | +$525K | 1.9% | 11 |
|
|
2015
Q4 | $24.1M | Sell |
238,361
-1,630
| -0.7% | -$170K | 2.1% | 9 |
|
|
2015
Q3 | $23.6M | Buy |
239,991
+5,230
| +2% | +$581K | 2.13% | 9 |
|
|
2015
Q2 | $27.5M | Buy |
234,761
+1,611
| +0.7% | +$176K | 2.33% | 8 |
|
|
2015
Q1 | $22.9M | Buy |
233,150
+3,125
| +1% | +$317K | 1.96% | 11 |
|
|
2014
Q4 | $23.1M | Buy |
230,025
+4,072
| +2% | +$421K | 2.02% | 9 |
|
|
2014
Q3 | $24.1M | Buy |
+225,953
| New | +$22.1M | 2.22% | 8 |
|
Other funds holding GILD
VCM
VPM
Arvest Bank Trust Division's GILD Position: Q1 2026 in Review
Arvest Bank Trust Division reduced its Gilead Sciences (GILD) stake by 16% in Q1 2026, selling an estimated $55.2K and leaving 2,011 shares worth $280K. The position accounts for 0.02% of the portfolio, ranked #192.
Arvest Bank Trust Division first reported a position in GILD in Q3 2014 and has held it in 36 quarters since. The position peaked at $27.5M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Arvest Bank Trust Division held 2,011 shares of Gilead Sciences worth $280K as of Q1 2026.
- Arvest Bank Trust Division sold 394 Gilead Sciences shares in Q1 2026, an estimated $55.2K.
- Gilead Sciences made up 0.02% of Arvest Bank Trust Division's portfolio in Q1 2026, its #192 holding.
- Arvest Bank Trust Division first reported a position in Gilead Sciences in Q3 2014 and has held it in 36 quarters since.
- Arvest Bank Trust Division's Gilead Sciences position peaked at $27.5M in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Arvest Bank Trust Division's 13F filing for Q1 2026, filed 13 May 2026.